Chimeric antigen receptor (CAR) T cell therapy is a personalized approach to treating certain blood cancers. Unlike traditional cancer therapies, autologous CAR T cell therapies are often administered as a one-time treatment made from a patient’s own cells. These cells are “programmed” during a sophisticated manufacturing process to help the T cells recognize and fight specific target cells, including some normal and cancer cells.
Format: PDF
Presented by BMS
Posted 4/2026
File Type:
pdf
File Size:
446 KB
Categories:
BMS, CAR T
